US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

142.74

-7.2700-4.85%

Post-market: 142.740.00000.00%16:21 EDT

Volume:710.70K

Turnover:104.58M

Market Cap:460.26M

PE:- -

High:154.44

Open:148.70

Low:139.62

Close:150.01

52wk High:198.18

52wk Low:32.55

Shares:3.22M

Float Shares:3.22M

Volume Ratio:1.09

T/O Rate:22.04%

Dividend:1.34

Dividend Rate:0.94%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Nvidia Expands Open Model Families to Support New Agentic, Physical, Healthcare AI

MT Newswires Live

Predict taps Mistral chief Cafagna to drive Digital Healthcare growth

Healthcare & Medical Investment Corp. Posts Modest Growth and Signals Flat Outlook

Dimerix's Alignment With US FDA on Phase Three 3 Disease Trial Endpoints, Review Process Suggests Productive Ongoing Dialogue, Euroz Hartleys Says

MT Newswires Live

Pinnacle dips below substantial holder threshold in Fisher & Paykel Healthcare

ASX Midday Sector Update: Real Estate Stocks Advance, Health Care Stocks Struggle

MT Newswires Live

Analysts’ Top Healthcare Picks: Oneview Healthcare Chess Depository Interests repr 1 (ONVVF), Spyre Therapeutics (SYRE)

Ispire Technology Highlights Economic Impact of FDA's New E-Cigarette Flavor Guidance, Foresees $50 Billion Market Unlock and Asset Value Surge

Viemed Healthcare Releases Updated March 2026 Investor Presentation

Health Care Up as Biotech Rebounds - Health Care Roundup

'Healthcare is important to me': I'm worried about relocating to Florida from New Jersey. Are hospitals there under stress?

Analysts Offer Insights on Healthcare Companies: Tarsus Pharmaceuticals (TARS) and Olema Pharmaceuticals (OLMA)

NRx Pharma Stock Jumps After FDA Signals Path To NDA For Ketamine Depression Drug

Benzinga_recent_news

Buy Rating on BioMarin: Strong Early Voxzogo Data, Real‑World Durability, and Underpenetrated Achondroplasia Opportunity Drive Upside

Analysts Offer Insights on Healthcare Companies: Mineralys Therapeutics, Inc. (MLYS) and Aprea Therapeutics (APRE)

GE Healthcare’s LUMINA Trial Positions New MRI Contrast Agent for Future Growth

Health Care Roundup: Market Talk

De-Risked Path to Market and Concentrated Rare Disease Opportunity Support Buy Rating on Savara’s Molbreevi

Fidia Advances POC Financing with New Share Issue to GGHL

Fortis Healthcare Reports No Requests Under SEBI Physical Share Transfer Window

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/LABU/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":142.74,"timestamp":1774036800000,"preClose":150.01,"halted":0,"volume":710702,"hourTrading":{"tag":"盘后","latestPrice":142.74,"preClose":142.74,"latestTime":"16:21 EDT","volume":633,"amount":90308.36292,"timestamp":1774038114907,"change":0,"changeRate":0,"amplitude":0.011139},"delay":0,"changeRate":-0.048463435770948485,"floatShares":3224486,"shares":3224486,"eps":0,"marketStatus":"Post-Mkt","change":-7.27,"latestTime":"03-20 16:23:06 EDT","open":148.7,"high":154.44,"low":139.6201,"amount":104580076.47377999,"amplitude":0.098793,"askPrice":144,"askSize":200,"bidPrice":141.4,"bidSize":200,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1774051200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":150.01,"sharesOutstanding":3074486,"nav":145.807,"aum":470151875.04,"dividendRate":0.009353,"bidAskSpread":0.002107,"preHourTrading":{"tag":"盘前","latestPrice":149.08,"preClose":150.01,"latestTime":"09:29 EDT","volume":2670,"amount":395890.9659,"timestamp":1774013390002,"change":-0.93,"changeRate":-0.0062,"amplitude":0.028865},"postHourTrading":{"tag":"盘后","latestPrice":142.74,"preClose":142.74,"latestTime":"16:21 EDT","volume":633,"amount":90308.36292,"timestamp":1774038114907,"change":0,"changeRate":0,"amplitude":0.011139},"volumeRatio":1.092169,"impliedVol":1.0281,"impliedVolPercentile":0.8486},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":3224486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.092169,"shares":3224486,"dividePrice":1.3351,"high":154.44,"amplitude":0.098793,"preClose":150.01,"low":139.6201,"week52Low":32.55,"pbRate":"--","week52High":198.18,"institutionHeld":0,"latestPrice":142.74,"eps":0,"divideRate":0.009353,"volume":710702,"delay":0,"ttmEps":0,"open":148.7,"prevYearClose":159.39,"prevWeekClose":148.85,"prevMonthClose":172.7,"prevQuarterClose":159.39,"fiveDayClose":148.85,"twentyDayClose":163.19,"sixtyDayClose":176.92},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2620440151","title":"Nvidia Expands Open Model Families to Support New Agentic, Physical, Healthcare AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2620440151","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620440151?lang=en_us&edition=fundamental","pubTime":"2026-03-17 17:22","pubTimestamp":1773739342,"startTime":"0","endTime":"0","summary":"Nvidia  said late Monday it is expanding its open model families to support new agentic, physical and healthcare artificial intelligence usage.The expanded portfolio includes Nemotron for agentic systems, Cosmos for physical AI, Alpamayo for autonomous vehicles, Isaac GR00T for robotics, and BioNeMo for biomedical research.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"07fde4bd3abdfcae1ed337fb0cbfa4c5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2236285917.USD","HK0000306685.HKD","LU0528227936.USD","SGXZ51526630.SGD","SG9999017495.SGD","LU1674673428.USD","LU2083900584.USD","LU2602419157.SGD","LU0823421416.USD","LU1923622291.USD","LU2168564495.EUR","LU0061475181.USD","LU0128525929.USD","SNVD.UK","NVD3.UK","LU1992135472.HKD","BK4551","BK4588","3NVD.UK","LU0823434583.USD","LU0985320562.USD","LU0689626769.HKD","IE00BMPRXN33.USD","LU2360107168.USD","LU0097036916.USD","LU1323610961.USD","SG9999018857.SGD","LU1868836757.USD","LU0353189680.USD","LU0965509101.SGD","LU2023251221.USD","LU1037948897.HKD","LU0310799852.SGD","LU1778281490.HKD","LU1127390331.HKD","LU0719512351.SGD","LU0048584097.USD","BK4527","NVIW.SI","IE00BKVL7J92.USD","LU1267930730.SGD","LU2250418816.HKD","LU2931357623.SGD","LU0708995401.HKD","LU1935042215.USD","LU2361044949.HKD","SG9999014906.USD","LU1989764664.SGD","LU2505996681.GBP","IE0009356076.USD","BK4587","LU0820561818.USD","LU2063271972.USD","LU2756315664.SGD","LU1691799644.USD","LU0345768740.USD","LU0154236417.USD","IE000W1ABFV2.USD","LU1989764748.USD","LU1923622614.USD","BK4532","LU2028103732.USD","NVD2.UK","SG9999014880.SGD","LU0354030438.USD","LU0266013472.USD","LU0211328371.USD","LU0943347566.SGD","IE0009G5SDU7.USD","LU2452424414.USD","IE0004445015.USD","LU2065171402.SGD","NVDY","LU1670756490.USD","LU0642271901.SGD","LU0390134368.USD","LU1623119135.USD","LU2125909247.SGD","BK4598","HK0000320264.USD","LU2247934214.USD","LU0096362180.USD","LU0823434740.USD","LU2092627202.USD","LU1316542783.SGD","LU0109391861.USD","LU2237957902.USD","LU2552382215.SGD","LU0210533765.USD","LU2286300806.USD","IE00BMPRXR70.SGD","LU0265550359.USD","LU0256863811.USD","SG9999001424.SGD","LU0672654240.SGD","LU2461242641.AUD","LU1366333091.USD","IE00B3S45H60.SGD","IE00BYXW3230.USD","LU1244550577.SGD","LU1917777945.USD","LU2361045086.USD","SG9999014898.SGD","LU0187121727.USD","LU0417517546.SGD","NVDS","LU2244417387.USD","LU1839511570.USD","IE00BDRTCR15.USD","LU0444973449.USD","IE0004086264.USD","LU1951200564.SGD","LU1934455277.USD","LU1988902786.USD","LU2111349929.HKD","LU0225283273.USD","LU0029864427.USD","BK4554","LU0211327993.USD","LU0203201768.USD","SG9999002232.USD","LU2471134796.USD","NVDB","IE00B3M56506.USD","LU1202635105.USD","LU0557290698.USD","LU2272731865.HKD","IE00BQXX3C00.GBP","IE00BKDWB100.SGD","LU0787776722.HKD","LU2322448791.USD","LU1712237335.SGD","IE00BK4W5L77.USD","LU0354030511.USD","LU0476273544.USD","LU0786609619.USD","IE0001KFT4U8.USD","BK4549","LU1718418525.SGD","IE00BQXX3F31.USD","LU1852331112.SGD","LU0868494617.USD","BK4141","LU1868837136.USD","LU2089985449.USD","LU1232071149.USD","BK4581","LU1242518931.SGD","LU1261432733.SGD","LU0251132253.USD","LU2413666699.HKD","LU0006306889.USD","LU1861220033.SGD","LU1119994496.HKD","IE00B1XK9C88.USD","LU0274383776.USD","HK0000914686.HKD","LU0061474705.USD","IE00BWXC8680.SGD","LU2413666426.HKD","LU2463028550.USD","IE0034235188.USD","IE00BKPKM429.USD","LU2360032135.SGD","LU2491050071.SGD","IE0034235303.USD","LU2097344357.USD","LU2023250504.SGD","LU1116320901.HKD","LU1804176565.USD","IE00BZ1G4Q59.USD","LU1435385759.SGD","LU0106261372.USD","LU1496350171.SGD","LU0861579265.USD","LU2322448957.HKD","LU1366192091.USD","LU2108987350.USD","LU2265009873.SGD","IE00B19Z9505.USD","LU1989772840.SGD","LU1720051017.SGD","LU2357125470.USD","LU0308772762.SGD","LU1571399168.USD","LU1861215975.USD","IE000ITXATA3.USD","IE00BN29S564.USD","BK4548","IE000KEQY171.SGD","LU2264538146.SGD","IE00BMPRXQ63.HKD","LU1868836591.USD","LU1548497426.USD","LU2168564149.EUR","LU2097344431.USD","LU2125909593.SGD","NVD","LU1868836914.USD","LU0082616367.USD","BK4534","IE00BZ199S13.USD","LU2168564222.USD","LU2896262040.SGD","LU0957808578.USD","LU1934455863.HKD","LU1699723380.USD","LU0081259029.USD","LU2237957811.SGD","LU0203202063.USD","LU2242650005.HKD","LU1064131342.USD","LU2089283258.USD","IE0003U64NQ7.SGD","LU0158827781.USD","LU1400636574.HKD","LU1551013342.USD","LU0210536198.USD","LU2272731600.USD","LU2420271590.USD","IE00BQXX3D17.EUR","IE0034235295.USD","LU0215105999.USD","BK4567","LU1267930573.SGD","LU2458330243.SGD","LU1914381329.SGD","LU2746668461.USD","LU2746668974.SGD","LU2430703095.HKD","LU2552382058.USD","SGXZ31699556.SGD","LABU","LU0882574139.USD","NVDA","BK4614","LU1066051811.HKD","NVDG","LU1145028129.USD","LU0310800379.SGD","BK4585","SG9999018865.SGD","LU2506951792.HKD","IE00BJLML261.HKD","IE00BJJMRX11.SGD","IE00B775H168.HKD","LU2417539215.USD","LU1066051225.USD","BK4605","SG9999000418.SGD","NVDD","SG9999014914.USD","LU0345770308.USD","NVDQ","SG9999015358.SGD","LU1815333072.USD","LU0823421333.USD","LU2065170008.USD","LU1244550221.USD","LU0942090050.USD","IE00B4JS1V06.HKD","SG9999015952.SGD","LU2294711713.HKD","LU0820562030.AUD","LU0107464264.USD","LU0109392836.USD","LU0683600562.USD","LU2462157665.USD","LU0345770993.USD","LU2473716301.USD","SG9999015341.SGD","LU1496350502.SGD","LU0057025933.USD","IE0004445239.USD","LU0347712357.USD","IE0005OL40V9.USD","IE00B5949003.HKD","LU0979878070.USD","LU0234570918.USD","SG9999015945.SGD","ANV","IE000YTNTUN2.SGD","LU0053666078.USD","SG9999015978.USD","LU0070217475.USD","LU0820561909.HKD","LU2360106780.USD","LU0238689110.USD","LU0788109477.HKD","LU2271345857.HKD","IE00BFSS8Q28.SGD","LU2125154935.USD","LU2361044865.SGD","LU1400636657.SGD","LU1629891620.HKD","BK4592","IE00B4YYXB79.USD","LU2592432038.USD","LU0965508806.USD","LU1791710400.SGD","IE00B775SV38.USD","LU0823414478.USD","IE00B19Z8W00.USD","LU2750360997.AUD","SG9999014542.SGD","IE00BHPRN162.USD","IE00BJTD4V19.USD","LU2487616109.SGD","LU1974910355.USD","SGXZ23171101.USD","BK4579","LU0096364046.USD","IE00BK4W5M84.HKD","LU2065169927.USD","LU1815336760.USD","LU1242518857.USD","LU1989772923.USD","LU0957791311.USD","BK4550","HK0000306701.USD","SG9999014559.SGD","GB00BDT5M118.USD","LU0466842654.USD","LU2458330169.SGD","LU0289961442.SGD","LU0724617625.USD","LU0965509010.AUD","LU0345769631.USD","LU0868494708.USD","LU0265550946.USD","LU2211815571.USD","LU1934455194.USD","LU2326559502.SGD","LU0256863902.USD","LU1642822529.SGD","LU2750360641.GBP","LU2125909916.SGD","LU1791710582.SGD","LU1868837300.USD","IE00BD6J9T35.USD","LU2106854487.HKD","NVDX","LU2125154778.USD","IE00BJTD4N35.SGD","LU0072462426.USD","LU0061474960.USD","BK4533","LU1244550494.USD","LU2471134879.HKD","IE00BJJMRY28.SGD","LU0158827948.USD","LU0342679015.USD","LU1551013425.SGD","LU1280957306.USD","LU2213496289.HKD","LU0964807845.USD","LU2433249047.HKD","HK0000914660.USD","LU1037948541.HKD","LU0494093205.USD","LU1035775433.USD","LU1066053197.SGD","LU1267930490.SGD","BK4608","LU2491050154.USD","LU0511384066.AUD","LU1821325948.USD","LU1861127337.USD","NVII","LU0080751232.USD","IE00B19Z8X17.USD","NVDU","LU0965509283.SGD","IE00B1BXHZ80.USD","LU0444971666.USD","LU0640476718.USD","LU0011850046.USD","LU2471134952.CNY","LU1674673691.USD","SGXZ99366536.SGD","LU0077335932.USD","LU2168564065.EUR","SGXZ81514606.USD","LU2403377893.USD","LU2089284900.SGD","LU0198837287.USD","NVDS.UK","LU0316494557.USD","SG9999004303.SGD","LU1983260115.SGD","LU0069063385.USD","LU2054465674.USD","IE00B3SWFQ91.USD","LU2381873111.SGD","LU2125909759.SGD","LU1935042488.USD","LU2272731782.SGD","LU1633808545.USD","LU0170899867.USD","LU1803068979.SGD","LU2543165471.USD","SG9999002224.SGD","LU1153585028.USD","2NVD.UK","BK4612","LU0124676726.USD","LU2471134523.USD","LU0889565833.HKD","LU2430703178.SGD","LU1935043023.USD","IE00B7KXQ091.USD","LU0267386448.USD","LU0079474960.USD","LU0157215616.USD","LU1066051498.USD","LU2456880835.USD","LU2756315318.SGD","LU0289739343.SGD","IE00BDCRKT87.USD","LU0094547139.USD","LU1951198990.SGD","LU1084165304.USD","LU1814569148.SGD","LU0353189763.USD","LU1645745479.HKD","LU0210528500.USD","LU2168563687.JPY","LU2430703251.USD","LU2077746001.SGD","LU2242649171.HKD","LU2505996509.AUD","BK4503","LU2092937148.SGD","XBI","SG9999014575.USD","SG9999014567.USD","LU2552382132.HKD","LU0472753341.HKD","LU1923623000.USD","LU1992135399.USD","LU0689472784.USD","LU2191332357.HKD","HK0000320223.HKD","LU0056508442.USD","LU2290526834.HKD","BK4529","LU2087621335.USD","LU0345769128.USD","LU0234572021.USD","DIPS","LU1069344957.HKD","LU0289960550.SGD","LU1721428933.USD","LU1400636491.USD","LU1935042991.SGD","SG9999015986.USD","LU2357305700.SGD","LU0320765059.SGD","LU0708994859.HKD","IE00BFSS7M15.SGD","LU1935043536.SGD","LU2065171311.SGD","LU1116320737.USD","LU0127658192.USD","LU2860962120.EUR","LU2023250330.USD","LU2249611893.SGD","LU0348723411.USD","LU0823414551.USD","LU0345768153.USD","LU1429558221.USD","LU2491049909.HKD","LU0323591593.USD","LU1720051108.HKD","LU2237438978.USD","LU0276348264.USD","LU2087625088.SGD","IE0004091025.USD","NVDW","BK4543","LU0175139822.USD"],"gpt_icon":0},{"id":"2620384444","title":"Predict taps Mistral chief Cafagna to drive Digital Healthcare growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2620384444","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620384444?lang=en_us&edition=fundamental","pubTime":"2026-03-17 15:56","pubTimestamp":1773734204,"startTime":"0","endTime":"0","summary":"Predict S.P.A. Class B ( ($IT:PRE) ) just unveiled an announcement. Predict S.p.A. has appointed long‑standing executive Isabella Cafagna as direct...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/predict-taps-mistral-chief-cafagna-to-drive-digital-healthcare-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/predict-taps-mistral-chief-cafagna-to-drive-digital-healthcare-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LU0029874061.USD","VGT","XLV","BK4585","HCSG","XBI","BK4588","LU0128526141.USD","BK4581","LABU"],"gpt_icon":0},{"id":"2620446954","title":"Healthcare & Medical Investment Corp. Posts Modest Growth and Signals Flat Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2620446954","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620446954?lang=en_us&edition=fundamental","pubTime":"2026-03-17 14:58","pubTimestamp":1773730730,"startTime":"0","endTime":"0","summary":"Healthcare & Medical Investment Corp ( ($JP:3455) ) has shared an announcement. Healthcare & Medical Investment Corp. reported modest growth for th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/healthcare-medical-investment-corp-posts-modest-growth-and-signals-flat-outlook?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/healthcare-medical-investment-corp-posts-modest-growth-and-signals-flat-outlook?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4581","XBI","BK4137","LU0029874061.USD","XLV","LU0128526141.USD","HCSG","BK4588","LABU"],"gpt_icon":0},{"id":"2620741030","title":"Dimerix's Alignment With US FDA on Phase Three 3 Disease Trial Endpoints, Review Process Suggests Productive Ongoing Dialogue, Euroz Hartleys Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2620741030","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620741030?lang=en_us&edition=fundamental","pubTime":"2026-03-17 12:39","pubTimestamp":1773722358,"startTime":"0","endTime":"0","summary":"Dimerix's (ASX:DXB) decision to conduct a blinded review of the Action3 phase 3 study data to confirm statistical assumptions of the primary endpoint after reaching alignment with the US Food and Drug","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK7508","BK7501","BK4585","DXB.AU","BK7067","LABU"],"gpt_icon":0},{"id":"2620958417","title":"Pinnacle dips below substantial holder threshold in Fisher & Paykel Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2620958417","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620958417?lang=en_us&edition=fundamental","pubTime":"2026-03-17 11:48","pubTimestamp":1773719289,"startTime":"0","endTime":"0","summary":"The latest update is out from Fisher & Paykel Healthcare Corporation Limited ( ($FSPKF) ). Pinnacle Investment Management Group Limited and its rel...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pinnacle-dips-below-substantial-holder-threshold-in-fisher-paykel-healthcare?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pinnacle-dips-below-substantial-holder-threshold-in-fisher-paykel-healthcare?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK8004","XLV","XBI","FPH.NZ","LABU","BK4581","BK4588","BK4585"],"gpt_icon":0},{"id":"2620419424","title":"ASX Midday Sector Update: Real Estate Stocks Advance, Health Care Stocks Struggle","url":"https://stock-news.laohu8.com/highlight/detail?id=2620419424","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620419424?lang=en_us&edition=fundamental","pubTime":"2026-03-17 09:55","pubTimestamp":1773712554,"startTime":"0","endTime":"0","summary":"Real estate stocks advanced nearly 1% at midday Tuesday.Goodman Group (ASX:GMG) gained more than 1% in recent trade.On the flip side, the health care sector struggled, shedding almost 1%.CSL (ASX:CSL) shares were down nearly 1% in recent trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XLV","BK7155","CSL.AU","BK7067","BK7510","BK7099","LABU","BK4585","BK4588","GMG.AU","BK4581","XBI","BK7501","BK7511","BK7508"],"gpt_icon":0},{"id":"2620557415","title":"Analysts’ Top Healthcare Picks: Oneview Healthcare Chess Depository Interests repr 1 (ONVVF), Spyre Therapeutics (SYRE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620557415","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620557415?lang=en_us&edition=fundamental","pubTime":"2026-03-17 08:40","pubTimestamp":1773708011,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Oneview Healthcare Chess Depository Interests repr 1...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-oneview-healthcare-chess-depository-interests-repr-1-onvvf-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-oneview-healthcare-chess-depository-interests-repr-1-onvvf-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","ONVVF","XLV","SYRE","BK4585","XBI","BK4167","BK4581","LABU","BK4139"],"gpt_icon":0},{"id":"1142698988","title":"Ispire Technology Highlights Economic Impact of FDA's New E-Cigarette Flavor Guidance, Foresees $50 Billion Market Unlock and Asset Value Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1142698988","media":"Stock News","labels":["policyRegulatory","economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142698988?lang=en_us&edition=fundamental","pubTime":"2026-03-17 08:32","pubTimestamp":1773707576,"startTime":"0","endTime":"0","summary":"Ispire Technology Inc. (ISPR.US) emphasized today that the U.S. Food and Drug Administration's (FDA) newly released draft guidance on evidence requirements for Premarket Tobacco Product Applications...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory,economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","06969","BK1580","BK1589","BK4588","BK4075","ISPR","BK4585","BK1242"],"gpt_icon":0},{"id":"2620924484","title":"Viemed Healthcare Releases Updated March 2026 Investor Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2620924484","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620924484?lang=en_us&edition=fundamental","pubTime":"2026-03-17 05:20","pubTimestamp":1773696043,"startTime":"0","endTime":"0","summary":"Viemed Healthcare ( ($VMD) ) just unveiled an announcement. Viemed Healthcare has released a new investor deck dated March 2026, which it plans to ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/viemed-healthcare-releases-updated-march-2026-investor-presentation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/viemed-healthcare-releases-updated-march-2026-investor-presentation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","HCSG","BK4588","BK4581","LABU","XBI","BK4585","LU0128526141.USD","LU0029874061.USD","XLV"],"gpt_icon":0},{"id":"2620644494","title":"Health Care Up as Biotech Rebounds - Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2620644494","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620644494?lang=en_us&edition=fundamental","pubTime":"2026-03-17 04:59","pubTimestamp":1773694740,"startTime":"0","endTime":"0","summary":"Health-care companies rose as a flight from high-risk market areas such as biotechnology slowed.The iShares Nasdaq Biotechnology exchange-traded fund, a basket of biotech firms, ticked up roughly 1%, but remains in the red for the year to date.British drugmaker AstraZeneca said it received European Union approval for its Imfinzi drug as a treatment for early-stage gastric and gastroesophageal cancers.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","XBI","XLV","BK4581","LABU"],"gpt_icon":0},{"id":"2620697494","title":"'Healthcare is important to me': I'm worried about relocating to Florida from New Jersey. Are hospitals there under stress?","url":"https://stock-news.laohu8.com/highlight/detail?id=2620697494","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620697494?lang=en_us&edition=fundamental","pubTime":"2026-03-17 04:58","pubTimestamp":1773694680,"startTime":"0","endTime":"0","summary":"MW 'Healthcare is important to me': I'm worried about relocating to Florida from New Jersey. Are hospitals there under stress?'The issue is not the weather, high insurance premiums or rising maintenance fees'. \"The hospitals in the New York/New Jersey area are outstanding.\" . I'm considering relocating from New Jersey to Florida, condo to condo. The cost of living - especially property taxes - can be challenging here. When you no longer have children in the school system, it's hard to justify the high property taxes in certain towns.The hospitals in the New York/New Jersey area are outstanding. As a senior, healthcare is important to me, and I'm thinking twice about moving. Unfortunately, I cannot afford to maintain two residences. I would welcome hearing your thoughts.Metropolitan areas tend to be better served. \"Rural hospitals continue to operate under significant financial pressure, with margins well below the national median and a growing share at immediate risk of closure,\" Medic","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0128526141.USD","BK4137","HCSG","BK4585","LU0029874061.USD","XBI","XLV","LABU","BK4581"],"gpt_icon":0},{"id":"2620410493","title":"Analysts Offer Insights on Healthcare Companies: Tarsus Pharmaceuticals (TARS) and Olema Pharmaceuticals (OLMA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620410493","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620410493?lang=en_us&edition=fundamental","pubTime":"2026-03-17 02:00","pubTimestamp":1773684030,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Tarsus Pharmaceuticals (TARS – Research Report) and ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-tarsus-pharmaceuticals-tars-and-olema-pharmaceuticals-olma-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-tarsus-pharmaceuticals-tars-and-olema-pharmaceuticals-olma-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","XLV","BK4505","LU0128526141.USD","OLMA","XBI","BK4139","BK4007","LABU","BK4137","LU0029874061.USD","BK4581","TARS","BK4585","HCSG"],"gpt_icon":0},{"id":"2620749845","title":"NRx Pharma Stock Jumps After FDA Signals Path To NDA For Ketamine Depression Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2620749845","media":"Benzinga_recent_news","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620749845?lang=en_us&edition=fundamental","pubTime":"2026-03-17 01:35","pubTimestamp":1773682500,"startTime":"0","endTime":"0","summary":"The FDA signals its willingness to review NRx Pharmaceuticals' NRX-100 NDA, boosting optimism around its depression treatment.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/16/Agitated-Depression-Mentioned.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/16/Agitated-Depression-Mentioned.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/fda/26/03/51277695/nrx-pharma-stock-jumps-after-fda-signals-path-to-nda-for-ketamine-depression-drug","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/fda/26/03/51277695/nrx-pharma-stock-jumps-after-fda-signals-path-to-nda-for-ketamine-depression-drug","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["SMA","BK4217","BK4588","BK4585","LABU"],"gpt_icon":0},{"id":"2620233498","title":"Buy Rating on BioMarin: Strong Early Voxzogo Data, Real‑World Durability, and Underpenetrated Achondroplasia Opportunity Drive Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2620233498","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620233498?lang=en_us&edition=fundamental","pubTime":"2026-03-17 01:25","pubTimestamp":1773681917,"startTime":"0","endTime":"0","summary":"BioMarin Pharmaceutical, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Yun Zhong from Wedbush maintained a B...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-on-biomarin-strong-early-voxzogo-data-real‑world-durability-and-underpenetrated-achondroplasia-opportunity-drive-upside-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-on-biomarin-strong-early-voxzogo-data-real‑world-durability-and-underpenetrated-achondroplasia-opportunity-drive-upside-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4581","XLV","BK4585","BK4588","XBI"],"gpt_icon":0},{"id":"2620460826","title":"Analysts Offer Insights on Healthcare Companies: Mineralys Therapeutics, Inc. (MLYS) and Aprea Therapeutics (APRE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620460826","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620460826?lang=en_us&edition=fundamental","pubTime":"2026-03-17 00:40","pubTimestamp":1773679205,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Mineralys Therapeutics, Inc. (MLYS – Research Report...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mineralys-therapeutics-inc-mlys-and-aprea-therapeutics-apre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-mineralys-therapeutics-inc-mlys-and-aprea-therapeutics-apre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4139","LU0029874061.USD","XBI","BK4588","MLYS","LABU","XLV","BK4581","HCSG","BK4137","BK4585","APRE"],"gpt_icon":0},{"id":"2620446033","title":"GE Healthcare’s LUMINA Trial Positions New MRI Contrast Agent for Future Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2620446033","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620446033?lang=en_us&edition=fundamental","pubTime":"2026-03-17 00:31","pubTimestamp":1773678700,"startTime":"0","endTime":"0","summary":"Ge Healthcare Technologies Inc. ($GEHC) announced an update on their ongoing clinical study. The LUMINA trial is a Phase 2/3 study run by GE Health...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ge-healthcares-lumina-trial-positions-new-mri-contrast-agent-for-future-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ge-healthcares-lumina-trial-positions-new-mri-contrast-agent-for-future-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1366333091.USD","LU1066051811.HKD","LU0354030438.USD","BK4206","BK4588","HCSG","LU0128526141.USD","LU1280957306.USD","LU2168563687.JPY","LU2168564149.EUR","LU2756315664.SGD","XLV","LU1066053197.SGD","LU0354030511.USD","LU2756315318.SGD","LU1084165304.USD","LU0077335932.USD","LU0157215616.USD","LU2168564495.EUR","LU1988902786.USD","LU1261432733.SGD","BK4543","LU1093756168.USD","LU1066051498.USD","LU1551013425.SGD","LU2264538146.SGD","BK4501","LU0640476718.USD","LU0267386448.USD","LU0820561909.HKD","BK4566","GE","LABU","BK4585","LU0868494617.USD","LU0820561818.USD","LU1093756325.SGD","LU1366192091.USD","LU2087625088.SGD","LU2168564065.EUR","BK4187","LU1551013342.USD","LU0353189763.USD","LU0689472784.USD","LU0820562030.AUD","LU2168564222.USD","XBI","LU0943347566.SGD","BK4581","BK4137"],"gpt_icon":0},{"id":"2620674214","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2620674214","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620674214?lang=en_us&edition=fundamental","pubTime":"2026-03-17 00:20","pubTimestamp":1773678000,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0305 ET - Q&M Dental Group  may benefit from potential completion of mergers and acquisitions, CGS International's Tay Wee Kuang says in a research report. On March 11, it unveiled a memorandum of understanding to acquire an Australian dental group for a consideration to be fulfilled on part-cash and part-shares basis, the analyst notes. By applying similar transaction details to the dental healthcare group's Thailand MOU and Singapore MOU announced on Oct. 15, 2025, and March 4, 2026, respectively, the brokerage estimates completion of the three M&As to boost 2027 EPS by 126.7%. CGS International raises the stock's target price to S$0.68 from S$0.49 with an unchanged add rating. Shares are 1.8% lower at S$0.545. (ronnie.harui","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","LABU","BK4585","BK4588","XBI","BK4581"],"gpt_icon":0},{"id":"2619462292","title":"De-Risked Path to Market and Concentrated Rare Disease Opportunity Support Buy Rating on Savara’s Molbreevi","url":"https://stock-news.laohu8.com/highlight/detail?id=2619462292","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619462292?lang=en_us&edition=fundamental","pubTime":"2026-03-16 23:35","pubTimestamp":1773675318,"startTime":"0","endTime":"0","summary":"Savara, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Andrew Fein from H.C. Wainwright maintained a Buy rati...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/de-risked-path-to-market-and-concentrated-rare-disease-opportunity-support-buy-rating-on-savaras-molbreevi-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/de-risked-path-to-market-and-concentrated-rare-disease-opportunity-support-buy-rating-on-savaras-molbreevi-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","XBI","XLV","LABU","BK4581"],"gpt_icon":0},{"id":"2619646224","title":"Fidia Advances POC Financing with New Share Issue to GGHL","url":"https://stock-news.laohu8.com/highlight/detail?id=2619646224","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619646224?lang=en_us&edition=fundamental","pubTime":"2026-03-16 23:34","pubTimestamp":1773675294,"startTime":"0","endTime":"0","summary":"Fidia Spa ( ($IT:FDA) ) has provided an announcement. Fidia S.p.A. has converted three bonds from the fourth tranche of its 2026 convertible bond w...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fidia-advances-poc-financing-with-new-share-issue-to-gghl?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fidia-advances-poc-financing-with-new-share-issue-to-gghl?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","VGT","BK4588"],"gpt_icon":0},{"id":"2619464869","title":"Fortis Healthcare Reports No Requests Under SEBI Physical Share Transfer Window","url":"https://stock-news.laohu8.com/highlight/detail?id=2619464869","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619464869?lang=en_us&edition=fundamental","pubTime":"2026-03-16 22:33","pubTimestamp":1773671614,"startTime":"0","endTime":"0","summary":"Fortis Healthcare Ltd. ( ($IN:FORTIS) ) just unveiled an announcement. Fortis Healthcare has informed the stock exchanges about the status of a spe...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fortis-healthcare-reports-no-requests-under-sebi-physical-share-transfer-window?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fortis-healthcare-reports-no-requests-under-sebi-physical-share-transfer-window?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU0128526141.USD","XBI","LU0029874061.USD","BK4588","XLV","LABU","BK4585","HCSG","BK4137"],"gpt_icon":0}],"pageSize":20,"totalPage":22,"pageCount":9,"totalSize":435,"code":"91000000","status":"200"}]}}